Councils - Pulmonary Transplantation
SCIENTIFIC COUNCIL ON PULMONARY TRANSPLANTATION Council Leadership Operating Board:COUNCIL CHAIR: NOT A COUNCIL MEMBER?
Council membership is open to all ISHLT members. Joining is easy. Simply login to the ISHLT Members Only Website
where you can update your membership profile and join any of the 11 Scientific Councils.
April 15-18, 2015
Nice, FRANCEJason D. Christie, MD, MS
(2014 Program Chair), Philadelphia, PA, USAPeter M Hopkins, FRACP
, Brisbane, AUSTRALIACassie C. Kennedy, MD
, Rochester, MN, USAFlorian M Wagner, MD
, Hamburg, GERMANYChristopher H. Wigfield, MD, FRCS(C/Th)
(Director of Educational Affairs), Chicago, IL, USAMartin R. Zamora, MD
, Aurora, Colorado, USA
for more details.
The resources below were developed by the ISHLT Pulmonary Transplantation Council QOL Workforce for clinicians and investigators alike. These resources aim to provide organized, up-to-date summaries of information focused on HRQL in lung transplantation.
This annotated bibliography of peer-reviewed publications focused on HRQL in lung transplantation is organized by theme including:
I. Determinants of HRQL
II. Psychosocial factors in HRQL
III. Comparisons of HRQL before and after lung transplantation
IV. Long-term longitudinal studies of HRQL in lung transplant recipients
V. The effect of therapies and interventions on HRQL
VI. Instrument validation and methodology
VII. HRQL as a predictor of clinical outcomes
VIII. Reviews and Editorials
This table is an organized list of the HRQL, health status and utility instruments used in studies examining HRQL in lung transplantation. In addition, links to the original manuscript that introduced each instrument and to the instrument webpage (if available) are provided.
If you are aware of new articles or resources that are missing, please email email@example.com
- Lung Transplantation Core Competency Curriculum (ISHLT LTx CCC) PDF
- DCD Guidelines PDF
University of Washington School of Medicine
Seattle, Washington, USA
firstname.lastname@example.orgDr. Michael S. Mulligan is an Endowed Professor in Lung Transplant Research, Chief of the Thoracic Surgery Section, Director of the Lung Transplant Program and Minimally Invasive Surgery Program as well as Director of the Cardiothoracic Research Laboratory at the University of Washington, Seattle, Washington, and one of the only surgeons in the Pacific Northwest who performs pulmonary endarterectomies for chronic pulmonary embolic disease. He organizes national courses in VATS lobectomy and critical care, and lectures internationally on lung transplantation and lung donor management. His laboratory has been consistently funded by the NIH and investigates mechanisms involved in acute lung transplant dysfunction. Dr. Mulligan attended medical school at the University of Connecticut. He completed his general surgery residency at Columbia Presbyterian in Noew York, NY and took time out during his residency for a two-year post doctoral research fellowship in the laboratory of Dr. Peter Ward at the University of Michigan in Ann Arbor, Michigan. He subsequently completed a heart and lung transplant fellowship at the University of Michigan, followed by a cardiothoracic residency at the University of Michigan and finally a general thoracic fellowship, also at the University of Michigan. During that final year in Ann Arbor, he traveled to San Diego to further study the diagnosis and treatment of Chronic Thromboembolic Hypertension.COUNCIL VICE CHAIR:
University of Pittsburgh Medical Center
email@example.comDr. Cynthia Gries is an Assistant Professor of Medicine and the Director of Outcomes Research at the University of Pittsburgh Medical Center (UPMC) in Pittsburgh, Pennsylvania. Dr. Gries received her Bachelorís Degree from Cornell University in Ithaca, New York and her medical degree at the University of Chicago, Pritzker School of Medicine in Chicago, Illinois. She subsequently completed her internal medicine residency at Johns Hopkins University in Baltimore, Maryland and her Pulmonary and Critical Care fellowship at the University of Washington in Seattle, Washington. In addition to her medical training, Dr. Gries has also obtained her Masterís Degree in Epidemiology from the University of Washington. Dr. Griesís research interests have focused on the role of health literacy and the informed consent process of lung transplant patients as well as its role in post-transplant adherence. She also has a strong interest in the role that the LAS has had on lung transplant allocation.COUNCIL PAST CHAIR:
Stanford University Medical Center
Stanford, California, USA
firstname.lastname@example.orgDavid Weill, MD, is Director of the Center for Advanced Lung Disease, the Adult Cystic Fibrosis Center and Medical Director of the Lung and Heart-Lung Transplant Program at Stanford University Hospitals and Clinics in Stanford, California. Dr. Weill received his medical degree from Tulane University School of Medicine, completed his residency at the University of Texas Southwestern Medical Center, and a fellowship at the University of Colorado School of Medicine. He is board certified in Pulmonary Disease and Creitical Care from the American Board of Internal Medicine.COUNCIL WORKFORCE LEADERS:
Univ of Michigan Health System
Ann Arbor, Michigan, USA
email@example.comKevin Chan, MD, is Medical Director of Lung Transplantation and Fellowship Program Director in the Division of Pulmonary and Critical Care Medicine at the University of Michigan in Ann Arbor, MI, USA. Dr. Chan received his medical degree from Wayne State University, completed his internal medicine residency at Rush Presbyterian St. Lukeís Medical Center in Chicago, and fellowship in Pulmonary and Critical Care Medicine at the University Of California Los Angeles Center for the Health Sciences.
Toronto General Hospital
Toronto, Ontario, CANADA
firstname.lastname@example.orgLianne Singer, MD, FRCPC is Medical Director of the Toronto Lung Transplant Program at the University Health Network in Toronto, Ontario, Canada. She is also Associate Professor in the Department of Medicine at the University of Toronto. She completed medical school, Internal Medicine and Respirology training at the University of Toronto. She went on to do a Lung and Heart-Lung Transplantation Fellowship at Stanford University, and advanced training in clinical research at the University of California, San Francisco. Dr. Singer's research interests arise directly from her clinical focus in lung transplantation and include health-related quality of life assessment in advanced lung disease and lung transplantation, telemedicine in lung transplantation, and clinical trials.
Washington University School of Medicine
St. Louis, MO, USA
email@example.comRoger Yusen, MD, MPH, is an Associate Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at Washington University School of Medicine (WUSM) in St. Louis, Missouri, USA. He is a lung transplant pulmonologist and the medical director of the lung volume reduction surgery program at WUSM and Barnes-Jewish Hospital. He focuses his research efforts on technology assessment in pulmonary and transplant medicine.
The Prince Charles Hospital
61-7-3350-8111Peter_Hopkins@health.qld.gov.auDr Peter Hopkins is the Director of the Quensland Lung Transplant Service and Associate Professor with the School of Medicine, University of Queensland, Brisbane. Research interests include First in Man clinical trials of innovative bronchoscopic techniques of lung volume reduction and development of novel treatment strategies for interstitial lung disease. Executive positions are held with the Australian Lung Foundation (PIVOT and the Australian IPF Registry), Deputy Chair of the Lung Standing Committee Transplant Society of Australia and New Zealand, Convenor SIG Interventional Bronchoscopy Thoracic Society of Australia and New Zealand and National Examiners Panel Royal Australian College of Physicians.COUNCIL LIAISONS:Board of Directors
St. Vincent's Hospital
firstname.lastname@example.orgProfessor Glanville trained in Sydney, Brompton Hospital, London and Stanford University, California. Currently working as a specialist in Lung Transplantation at St. Vincent's Hospital Sydney, he is actively involved with international trials into new immunosuppressive and anti-viral agents. He is Global Principal Investigator for the European and Australian Investigators in Lung Transplantation CeMyLungs trial, and sits on the Editorial Board of the American Journal of Respiratory and Critical Care Medicine. He has authored over 140 publications including approaches to antibody mediated rejection, bronchoscopic surveillance, RSV, CMV, Chlamydia and mycobacteria. He is the senior author of the International Guidelines for Lung Transplantation, foundation director of Outcomes Australia and a foundation member of ShareLife Australia.
Duke University Medical Center
Durham, NC, USA
email@example.comDr. Davis is Professor of Cardiovascular & Thoracic Surgery and the Director of Transplant Services at Duke University Medical Center. He received his MD in 1984 from the University of California Los Angeles David Geffen School of Medicine. He received his post graduate training at Duke University Medical Center and Barnes-Jewish Hospital, Washington University in St. Louis, Missouri. His clinical interests are in adult cardiac surgery and cardiothoracic transplantation (lung, heart-lung, and heart); coronary artery revascularization, including minimally invasive and hybrid procedures; valve repair and replacement surgery; surgical treatment of chronic thromboembolic pulmonary hypertension and chronic atrial fibrillation.
Toronto General Hospital/UHN
Toronto, ON, CANADA
firstname.lastname@example.orgTereza Martinu is a lung transplant respirologist with the Toronto Lung Transplant Program at the University Health Network in Toronto, Ontario, Canada. She is also Assistant Professor of Medicine and Clinician-Scientist at the University of Toronto. Dr. Martinu obtained her Medical Degree from McGill University in Montreal, Canada. She subsequently completed training in Internal and then Pulmonary and Critical Care Medicine at Duke University, in North Carolina, USA, before joining the Duke Lung Transplant Program. She transitioned to the Toronto program in August of 2014. In her clinical time, Dr. Martinu cares for lung transplant patients and candidates. In her research time, she studies immunological and cellular mechanisms of chronic lung allograft dysfunction in humans as well as in animal models.
The Prince Charles Hospital
61-7-31394000Daniel_Chambers@health.qld.gov.auDan Chambers, MBBS MRCP FRACP MD, is a Thoracic and Transplant Physician and Head of Research in the Queensland Lung Transplant Service, Prince Charles Hospital, Brisbane, Australia. He is also Associate Professor in the School of Medicine, University of Queensland, and Deputy Chair of the Metropolitan North Human Research and Ethics Committee. He is a member of the Lung Standing Committee for the Transplantation Society of Australia and New Zealand, and the Research Subcommittee for the Thoracic Society of Australia and New Zealand. His main research interests include the pathogenesis of chronic lung allograft dysfunction, early detection of lymphocytic bronchiolitis, lung metagenomics, adult lung disease complicating extreme preterm birth and cell therapy for advanced lung disease.
University Hospital Gasthuisberg
email@example.comRobin Vos, MD, PhD, is Assistant Professor of Pulmonary Medicine at the Katholieke Universiteit and University Hospital Gasthuisberg, Leuven, Belgium. He obtained his undergraduate degree in Medicine at the Faculty of Medicine, Katholieke Universiteit Leuven, Belgium in 2004, after which he completed his Residency in Internal and Pulmonary Medicine at the University Hospital Gasthuisberg, Leuven, Belgium in 2012. From 2006 until 2010 he performed his PhD fellowship in the lab of Pneumology, Katholieke Universiteit Leuven, Belgium under the supervision of Prof. dr. GM. Verleden. His clinical and research interests include the pathophysiology and treatment of acute and chronic lung allograft rejection.